Clinical Trial Update: A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration [Phase 4]

View source ↗

Summary

Phase 4 study in Japan evaluating the safety and potential efficacy of ASP3021 eye injections for vision loss due to Geographic Atrophy and Age-related Macular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• ASP3021

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Geographic Atrophy, Age-Related Macular Degeneration | Phase 4 | Status: RECRUITING